Evaluation of Quality of Life Related to I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer and Emphasis in Salivary Morbidity: A Follow up Study after Treatment

Journals Menu

Follow SCIRP

ISSN Print: 2156-8456
ISSN Online: 2156-8502
www.scirp.org/journal/abb
E-mail: abb@scirp.org

"Evaluation of Quality of Life Related to I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer and Emphasis in Salivary Morbidity: A Follow up Study after Treatment"
written by Lucélia Garcia Corrêa, Sônia Marta Moriguchi, Érica Boldrini, André Lopes de Carvalho, José Humberto Tavares Guerreiro Fregnani, Euclides Timóteo da Rocha,
published by Advances in Bioscience and Biotechnology, Vol.5 No.5, 2014

has been cited by the following article(s):

[1]	Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine
	2021

[2]	PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy
	2020

Follow SCIRP